title: Polymyalgia rheumatica occurring during treatment with ipilimumab.
authors.affiliation: Department of Dermatology.
authors.forename: Christa
authors.initials: C
authors.lastname: Maniu
authors.affiliation: Department of Nuclear Medicine, University of Cologne, 50937 Cologne, Germany.
authors.forename: Carsten
authors.initials: C
authors.lastname: Kobe
authors.affiliation: Department of Dermatology.
authors.forename: Max
authors.initials: M
authors.lastname: Schlaak
authors.affiliation: Department of Dermatology.
authors.forename: Cornelia
authors.initials: C
authors.lastname: Mauch
authors.affiliation: Department of Dermatology.
authors.forename: Sabine A
authors.initials: SA
authors.lastname: Eming
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D000074324:Ipilimumab; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D011111:Polymyalgia Rheumatica / Q000139:chemically induced* / Q000000981:diagnostic imaging; D000072078:Positron Emission Tomography Computed Tomography; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab